These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 38950453
1. Short and long-term effect of polycarbophil vaginal gel on vaginal atrophy of peri- and post-menopausal women. The TRIPLE study. Cagnacci A, Franco Barattini D, Casolati E, Mangrella M, Piccolo E, Piazza R, Pecoroni A, Rosu S, Cristian Pătrașcu L. Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():303-308. PubMed ID: 38950453 [Abstract] [Full Text] [Related]
3. Safety and efficacy of a class II medical device based on highly purified and standardized plant extracts in the management of post-menopausal patients with vulvar and vaginal atrophy: a single-center prospective observational study. Galli V, Golia D'Augè T, DI Pierro F, Cazzaniga M, Guasti L, Zerbinati N, Bertuccioli A, Khan A, D'Ovidio G, Iaculli F, Tibaldi V, Santangelo G, Fischetti M, Casorelli AF, DI Donato V, Giannini A, Musella A, Giancotti A, Monti M. Minerva Obstet Gynecol; 2024 Aug; 76(4):343-352. PubMed ID: 38358384 [Abstract] [Full Text] [Related]
4. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom. Archer DF, Kimble TD, Lin FDY, Battucci S, Sniukiene V, Liu JH. J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980 [Abstract] [Full Text] [Related]
5. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial. Fernandes T, Costa-Paiva LH, Pedro AO, Baccaro LF, Pinto-Neto AM. Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462 [Abstract] [Full Text] [Related]
9. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial. Zohrabi I, Abedi P, Ansari S, Maraghi E, Shakiba Maram N, Houshmand G. BMC Womens Health; 2020 May 19; 20(1):108. PubMed ID: 32429977 [Abstract] [Full Text] [Related]
11. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction. Vale F, Rezende C, Raciclan A, Bretas T, Geber S. Eur J Obstet Gynecol Reprod Biol; 2019 Mar 19; 234():92-95. PubMed ID: 30677618 [Abstract] [Full Text] [Related]
18. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Caruso S, Cianci S, Amore FF, Ventura B, Bambili E, Spadola S, Cianci A. Menopause; 2016 Jan 19; 23(1):47-54. PubMed ID: 26079974 [Abstract] [Full Text] [Related]
19. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Biglia N, Peano E, Sgandurra P, Moggio G, Panuccio E, Migliardi M, Ravarino N, Ponzone R, Sismondi P. Gynecol Endocrinol; 2010 Jun 19; 26(6):404-12. PubMed ID: 20196634 [Abstract] [Full Text] [Related]
20. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study. Cano A, Estévez J, Usandizaga R, Gallo JL, Guinot M, Delgado JL, Castellanos E, Moral E, Nieto C, del Prado JM, Ferrer J. Menopause; 2012 Oct 19; 19(10):1130-9. PubMed ID: 22914208 [Abstract] [Full Text] [Related] Page: [Next] [New Search]